NervGen Pharma Financial Overview
NervGen Pharma's market cap is currently C$540.73M. The company's EPS TTM is C$-0.06; its P/E ratio is -19.08; NervGen Pharma is scheduled to report earnings on November 24, 2025, and the estimated EPS forecast is C$-0.05. See an overview of income statement, balance sheet, and cash flow financials.
